China Medical Tech. (CMED) Reports Strong Q4 Results
China Medical Technologies, Inc. (Nasdaq: CMED) reports Q4 EPS of $0.60, versus the analyst estimate of $0.43. Revenue for the quarter was $36 million, versus the consensus of $35.28 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
- PVH Corp. (PVH) Tops Q1 EPS by 4c; Guides FY12 EPS
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
